Metraipolis › archive › dc_d45e36de7d87

Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan — Europe PMC PMID:39693189

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39693189
DOI
10.1080/21645515.2024.2435142
License (as archived)
CC0-1.0
Archived
2026-10-08T14:08:40.224Z
SHA-256 of the archived text
71142059f720dd97965a532b4831661134c5247c5b49d39413d9be51c0bc2d3d
Stable URL of this page
https://metraipolis.com/documento/dc_d45e36de7d87

How to cite

Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan — Europe PMC PMID:39693189 — Europe PMC (en), https://europepmc.org/article/MED/39693189 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d45e36de7d87 (Metraipolis archive dc_d45e36de7d87, sha256 71142059f720dd97965a532b4831661134c5247c5b49d39413d9be51c0bc2d3d)
BibTeX
@misc{dcd45e36de7d87,
  title = {Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan — Europe PMC PMID:39693189},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39693189},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d45e36de7d87; sha256 71142059f720dd97965a532b4831661134c5247c5b49d39413d9be51c0bc2d3d},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/39693189. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Healthcare workers (HCW) have high occupational risk for hepatitis B and Uzbekistan held two HCW vaccination campaigns in 2015 and 2022. Hepatitis B antibody testing (anti-HBs) after Hepatitis B (HepB) vaccination is recommended by the U.S. CDC and WHO for HCW, but Uzbekistan does not have such a policy. In 2023, we randomly selected HCW from the campaign registries. Participants who agreed were interviewed at their workplaces. Vaccination doses were self-reported. Testing for hepatitis B surface antigen (HBsAg), Total hepatitis B core antibody (anti-HBc), and anti-HBs were concurrently performed. We used multivariable Poisson regression to assess factors associated with anti-HBs ≥10 mIU/mL. Of 334 participants, 205 were vaccinated in 2015 and 129 in 2022. Median age was 40 years (interquartile range 35-49 years), and 87% were female. Most (71%) reported having completed the three doses, 21% two doses and 7% one dose. Testing revealed that 5% had an active HBV infection, 4% had a resolved infection, and 91% had detectable vaccine-derived antibodies. Among those ( n = 303), 71% had anti-HBs ≥10 mIU/mL. For those who reported receiving 1, 2, and 3 doses, protective titers were 59%, 70%, and 72%, respectively. Protective titers were lower for HCW that worked in clinics versus hospitals (aPR = 0.92, CI: 0.87-0.98, p = .01) adjusting for age, dose number and presence of chronic conditions. Strategies to improve completion of the 3-dose series and policies for post-vaccination immunity testing 1-2 months after completion of the 3-dose HepB series could help identify workers who may require revaccination or are currently infected.

Tema degli esploratori: scienze della vita e salute (ricerca Europe PMC «epidemiology», solo open access).
Pubblicazione: Human vaccines & immunotherapeutics, 2024 (prima pubblicazione 2024-12-18).
Identificativi: PMID 39693189 · PMCID PMC11789720 · DOI 10.1080/21645515.2024.2435142.
Parole chiave degli autori: Hepatitis B virus; Immunization; Vaccination; Hepatitis B antibodies; Health Personnel; Uzbekistan; Immunization Programs.
Descrittori MeSH principali: Hepatitis B; Hepatitis B Vaccines; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Health Personnel.
Pagina: https://europepmc.org/article/MED/39693189 — https://doi.org/10.1080/21645515.2024.2435142. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-08T13:23:59.882Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.